Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Thyroid Carcinoma, Anaplastic × dabrafenib × Clear all

Phase

Status

Recruiting 3 Active not recruiting 2 Withdrawn 1 Suspended 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Head & Neck 1 Endocrine 1 Dermatologic 1

Conditions

Thyroid Carcinoma, Anaplastic 1 Neoplasms 1 Melanoma 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04418167 2025-09-03

JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations

JS InnoPharm, LLC

Phase 1 Suspended

DermatologicEndocrineHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma, Neoplasms, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡